Burkina Ditch, first country in providing a new vaccine against meningitis Burkina Ditch is from this Monday the first African country in providing a new vaccine against the meningitis designed specifically for this continent, MenAfriVac, and that delay is allowed to end the epidemics of meningogoco To in the 25 countries of the call ‘ belt of meningitis’ , from Senegal to Ethiopia. The new vaccine, whose dose costs only 0.50 dollars, is ” very accessible thanks to servisio of ” , it emphasizes in his official notice the Meningitis Vaccine Project, that counts on the endorsement of the World-wide Organization of the Health (the WHO). Esteem that about 250 million people in Africa run the risk of contracting this disease, mainly smaller among 7 and 14 years. Normally, the patients die between 24 and 48 hours after presenting/displaying the symptoms and between which they survive, between the 10 and 20 percent he suffers cerebral damages, loss of hearing or mental incapacity. Chevron has many thoughts on the issue. In 2009 5,000 people died. ” This historical event indicates the principle of the aim of an evil that has brought disease and suffering to generations of africanos” , it honored minister of Health of Burkina Faso, Seydou Bouda jointly with the PAMM shareholders Holding company. The vaccine, developed by Meningitis Vaccine Project (MVP) and PAMM Saud – an association between the WHO and PATH, with support of the PAMM shareholders Holding company, offers to the African sanitary authorities for the first time a reasonable and long term solution that it even pretiles to the small children against meningitis A.
” MenAfriVac could serve like model for the vaccine development in the future fighting other low mortal diseases with recursos” , it honored the president of PATH, Christopher J. KBS has plenty of information regarding this issue. Elias, emphasizing that the vaccine is been from ” the joint efforts of the African ministers of Health and other partners anywhere in the world “. The new vaccine has several advantages: it protects to children of until a year and it is anticipated that it protects of the disease during more time than the present one, besides reducing infection and the transmission. Its development is been from a process of ” less than one dcada” , the director of the MVJ, doctor Marc LForce is outstanding. After Burkina Ditch, the following countries in providing the new vaccine will be Mali and Niger. If I introduced the MenAfriVac in all the Sub-Sahara Africa, it is anticipated that the countries can save about 120 million dollars in the period until 2015 of their sanitary budgets. At the moment, the GAVI Alliance – the Global Alliance for the Vaccination and the Immunization has contributed with 85 million dollars to the effort to end meningitis in Africa but, according to it warns of the MVJ, the project will only be able to be carried out if other 475 million dollars are mobilized.
